CAMBRIDGE NUTRITIONAL SCIENCES PLC — Director's Dealing 2022

Sep 16, 2022

National Storage Mechanism | Additional information

RNS Number : 7828Z

Omega Diagnostics Group PLC

16 September 2022

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Purchase of Shares by Directors

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces the following Director purchases of, in aggregate, 819,181 ordinary shares in the Company:

Name	Position	Number of Ordinary Shares Purchased	Price per Ordinary Share	Resultant Shareholding	Percentage of Issued Share Capital
Simon Douglas	Chairman	260,001	2.88p	760,001	+0.32%
Jag Grewal	Chief Executive Officer	159,180	2.89p	894,926	+0.38%
Chris Lea	Chief Financial Director	400,000	2.81p	900,000	+0.38%

Contacts: 

Omega Diagnostics Group PLC		www.omegadx.com
Jag Grewal, Chief Executive Officer		via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd		Tel: 020 7220 0500
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
Alice Lane/Charlotte Sutcliffe (ECM)
Walbrook PR Limited	Tel: 020 7933 8780 or [email protected]
Paul McManus	Mob: 07980 541 893

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.

www.omegadx.com

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Simon Douglas
2.	Reason for the notification
a.	Position/status	Chairman
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Omega Diagnostics Group plc
b.	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary Shares of 4 pence each  ISIN: GB00B1VCP282
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	2.88 pence 260,001 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	15 September 2022
f.	Place of the transaction	London Stock Exchange

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Jag Grewal
2.	Reason for the notification
a.	Position/status	Chief Executive Officer
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Omega Diagnostics Group plc
b.	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary Shares of 4 pence each  ISIN: GB00B1VCP282
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	2.89 pence 159,180 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	15 September 2022
f.	Place of the transaction	London Stock Exchange

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Chris Lea
2.	Reason for the notification
a.	Position/status	Chief Financial Officer
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Omega Diagnostics Group plc
b.	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary Shares of 4 pence each  ISIN: GB00B1VCP282
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	2.81 pence 400,000 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	15 September 2022
f.	Place of the transaction	London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUNARRUAUKAAR